Interaction Between microRNA and DNA Methylation in Atherosclerosis

Area of Science:

• Molecular Biology
• Epigenetics
• Cardiovascular Disease Research

Background:

• Atherosclerosis (AS) is a chronic inflammatory disease characterized by endothelial dysfunction, foam cell formation, and vascular smooth muscle cell proliferation.
• Gene expression regulation at transcriptional and post-transcriptional levels offers therapeutic avenues for AS.
• Epigenetic modifications, including DNA methylation and microRNAs (miRNAs), significantly influence cellular functions and disease development.

Purpose of the Study:

• To review the current understanding of microRNA (miRNA) and DNA methylation roles in atherosclerosis (AS) progression.
• To explore the intricate mutual regulatory mechanisms between DNA methylation and miRNAs in the context of AS.
• To provide insights into potential therapeutic targets based on epigenetic interactions in AS.

Main Methods:

• Comprehensive literature review of recent studies on DNA methylation, miRNAs, and their interactions in atherosclerosis.
• Analysis of existing research focusing on the epigenetic regulation of AS-related genes.
• Synthesis of findings on the interplay between DNA methylation and miRNA pathways in AS pathogenesis.

Main Results:

• Both DNA methylation and miRNAs are critical epigenetic regulators involved in various stages of AS.
• Emerging evidence reveals a significant mutual regulatory relationship between DNA methylation and miRNA expression in AS.
• These epigenetic interactions collectively contribute to the complex pathological changes observed in atherosclerosis.

Conclusions:

• The interplay between DNA methylation and miRNAs represents a crucial layer of epigenetic control in atherosclerosis.
• Understanding these interactions is vital for developing novel diagnostic and therapeutic strategies for AS.
• Targeting the mutual regulation of DNA methylation and miRNAs holds promise for future AS interventions.